|
Market Closed -
Australian S.E.
08:10:12 13/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 7.420 AUD | -2.88% |
|
-1.33% | -40.45% |
| 11-07 | Clinuvel Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 10-30 | Clinuvel Pharmaceuticals Ltd Files Neuracthel Instant Dossier | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Biopharmaceuticals | -2.88% | -1.33% | -40.45% | -33.03% | -76.94% | 254M |  |  | |
- Stock Market
- Stocks
- CUV Stock
- Charts Clinuvel Pharmaceuticals Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
